Multi-regional

Parcesepe, Angela M.; Stockton, Melissa; Bernard, Charlotte; Kanguya, Tukiya; Kwobah, Edith Kamaru et al. (2024). Prevalence and co-occurrence of symptoms of mental and substance use disorders among people with HIV age 40 and older in low- and middle-income countries: a cross-sectional study. Journal of the International AIDS Society, 27 (10), S. e26359. http://doi.org/10.1002/jia2.26359.

Kuniholm, Mark H.; Murenzi, Gad; Shumbusho, Fabienne; Brazier, Ellen; Plaisy, Marie K. et al. (2024). Association of cardiovascular disease risk with liver steatosis and fibrosis in people living with hiv in low- and middle-income countries. AIDS (London, England). http://doi.org/10.1097/QAD.0000000000004012.

Zaniewski, Elizabeth; Skrivankova, Veronika Whitesell; Brazier, Ellen; Avihingsanon, Anchalee; Cardoso, Sandra Wagner et al. (2024). Transition to dolutegravir-based ART in 35 low- and middle-income countries: a global survey of HIV care clinics. AIDS (London, England). http://doi.org/10.1097/QAD.0000000000004007.

Egger, Matthias; Sauermann, Mamatha; Loosli, Tom; Hossmann, Stefanie; Riedo, Selma et al. (2024). HIV-1 subtype-specific drug resistance on dolutegravir-based antiretroviral therapy: protocol for a multicentre study (DTG RESIST). BMJ Open, 14 (8), S. e085819. http://doi.org/10.1136/bmjopen-2024-085819.

Kebede, Samuel; Brazier, Ellen; Freeman, Aimee M.; Muwonge, Timothy R.; Choi, Jun Yong et al. (2024). Preexposure prophylaxis availability among health facilities participating in the global International epidemiology Databases to Evaluate AIDS (IeDEA) consortium. AIDS (London, England), 38 (5), S. 751–756. http://doi.org/10.1097/QAD.0000000000003824.

Plaisy, Marie Kerbie; Minga, Albert K.; Wandeler, Gilles; Murenzi, Gad; Samala, Niharika et al. (2024). Metabolic causes of liver disease among adults living with HIV from low- and middle-income countries: a cross-sectional study. Journal of the International AIDS Society, 27 (4), S. e26238. http://doi.org/10.1002/jia2.26238.

Brazier, Ellen; Tymejczyk, Olga; Wools-Kaloustian, Kara; Jiamsakul, Awachana; Torres, Marco Tulio Luque et al. (2024). Long-term HIV care outcomes under universal HIV treatment guidelines: A retrospective cohort study in 25 countries. PLoS Medicine, 21 (3), S. e1004367. http://doi.org/10.1371/journal.pmed.1004367.

Davidović, Maša; Asangbeh, Serra Lem; Taghavi, Katayoun; Dhokotera, Tafadzwa; Jaquet, Antoine et al. (2024). Facility-Based Indicators to Manage and Scale Up Cervical Cancer Prevention and Care Services for Women Living With HIV in Sub-Saharan Africa: a Three-Round Online Delphi Consensus Method. Journal of Acquired Immune Deficiency Syndromes (1999), 95 (2), S. 170–178. http://doi.org/10.1097/QAI.0000000000003343.

Lancaster, Kathryn E.; Stockton, Melissa; Remch, Molly; Wester, C. William; Nash, Denis et al. (2024). Availability of substance use screening and treatment within HIV clinical sites across seven geographic regions within the IeDEA consortium. The International Journal on Drug Policy, 124, S. 104309. http://doi.org/10.1016/j.drugpo.2023.104309.

Enane, Leslie A.; Duda, Stephany N.; Chanyachukul, Thida; Bolton-Moore, Carolyn; Navuluri, Neelima et al. (2024). The Tuberculosis Sentinel Research Network (TB-SRN) of the International epidemiology Databases to Evaluate AIDS (IeDEA): protocol for a prospective cohort study in Africa, Southeast Asia and Latin America. BMJ Open, 14 (1), S. e079138. http://doi.org/10.1136/bmjopen-2023-079138.

Global variations in pubertal growth spurts in adolescents living with perinatal HIV (2023). AIDS (London, England), 37 (10), S. 1603–1615. http://doi.org/10.1097/QAD.0000000000003602.

Parcesepe, Angela M.; Stockton, Melissa; Remch, Molly; Wester, C. William; Bernard, Charlotte et al. (2023). Availability of screening and treatment for common mental disorders in HIV clinic settings: data from the global International epidemiology Databases to Evaluate AIDS (IeDEA) Consortium, 2016-2017 and 2020. Journal of the International AIDS Society, 26 (8), S. e26147. http://doi.org/10.1002/jia2.26147.

Person, Anna K.; Crabtree-Ramirez, Brenda; Kim, Ahra; Veloso, Valdiléa; Maruri, Fernanda et al. (2023). Cryptococcal Meningitis and Clinical Outcomes in Persons With Human Immunodeficiency Virus: A Global View. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 76 (12), S. 2116–2125. http://doi.org/10.1093/cid/ciad076.

Vreeman, R. C.; Yiannoutsos, C. T.; Yusoff, N. K. N.; Wester, C. W.; Edmonds, A. et al. (2023). Global HIV prevention, care and treatment services for children: a cross-sectional survey from the International Epidemiology Databases to Evaluate AIDS (IeDEA) consortium. BMJ Open, 13 (3), S. e069399. http://doi.org/10.1136/bmjopen-2022-069399.

Ross, J.; Brazier, E.; Fatti, G.; Jaquet, A.; Tanon, A. et al. (2023). Same-Day Antiretroviral Therapy Initiation as a Predictor of Loss to Follow-up and Viral Suppression Among People With Human Immunodeficiency Virus in Sub-Saharan Africa. Clin Infect Dis, 76 (1), S. 39–47. http://doi.org/10.1093/cid/ciac759.

Humphrey, John; Nagel, Elizabeth; Carlucci, James G.; Edmonds, Andrew; Kinikar, Aarti et al. (2023). Integration of HIV care into maternal and child health services in the global IeDEA consortium. Frontiers in Global Women’s Health, 4, S. 1066297. http://doi.org/10.3389/fgwh.2023.1066297.

Lotspeich, Sarah C.; Shepherd, Bryan E.; Kariuki, Marion Achieng; Wools-Kaloustian, Kara; McGowan, Catherine C. et al. (2023). Lessons learned from over a decade of data audits in international observational HIV cohorts in Latin America and East Africa. Journal of Clinical and Translational Science, 7 (1), S. e245. http://doi.org/10.1017/cts.2023.659.

Brazier, E.; Maruri, F.; Wester, C. W.; Musick, B.; Freeman, A. et al. (2023). Design and implementation of a global site assessment survey among HIV clinics participating in the International epidemiology Databases to Evaluate AIDS (IeDEA) research consortium. PLoS One, 18 (3), S. e0268167. http://doi.org/10.1371/journal.pone.0268167.

Brazier, E.; Ajeh, R.; Maruri, F.; Musick, B.; Freeman, A. et al. (2022). Service delivery challenges in HIV care during the first year of the COVID-19 pandemic: results from a site assessment survey across the global IeDEA consortium. J Int AIDS Soc, 25 (12), S. e26036. http://doi.org/10.1002/jia2.26036.

Marti, M.; Zurcher, K.; Enane, L. A.; Diero, L.; Marcy, O. et al. (2022). Impact of the COVID-19 pandemic on TB services at ART programmes in low- and middle-income countries: a multi-cohort survey. J Int AIDS Soc, 25 (10), S. e26018. http://doi.org/10.1002/jia2.26018.

Romo, M. L.; Edwards, J. K.; Semeere, A. S.; Musick, B. S.; Urassa, M. et al. (2022). Viral Load Status Before Switching to Dolutegravir-Containing Antiretroviral Therapy and Associations With Human Immunodeficiency Virus Treatment Outcomes in Sub-Saharan Africa. Clin Infect Dis, 75 (4), S. 630–637. http://doi.org/10.1093/cid/ciab1006.

Wada, P. Y.; Kim, A.; Jayathilake, K.; Duda, S. N.; Abo, Y. et al. (2022). Site-Level Comprehensiveness of Care Is Associated with Individual Clinical Retention Among Adults Living with HIV in International Epidemiology Databases to Evaluate AIDS, a Global HIV Cohort Collaboration, 2000-2016. AIDS Patient Care STDS, 36 (9), S. 343–355. http://doi.org/10.1089/apc.2022.0042.

Edmonds, A.; Brazier, E.; Musick, B. S.; Yotebieng, M.; Humphrey, J. et al. (2022). Clinical and programmatic outcomes of HIV-exposed infants enrolled in care at geographically diverse clinics, 1997-2021: A cohort study. PLoS Med, 19 (9), S. e1004089. http://doi.org/10.1371/journal.pmed.1004089.

Romo, M. L.; Brazier, E.; Mahambou-Nsonde, D.; De Waal, R.; Sekaggya-Wiltshire, C. et al. (2022). Real-world use and outcomes of dolutegravir-containing antiretroviral therapy in HIV and tuberculosis co-infection: a site survey and cohort study in sub-Saharan Africa. J Int AIDS Soc, 25 (7), S. e25961. http://doi.org/10.1002/jia2.25961.

Lewis, J. T.; Stephens, J.; Musick, B.; Brown, S.; Malateste, K. et al. (2022). The IeDEA harmonist data toolkit: A data quality and data sharing solution for a global HIV research consortium. J Biomed Inform, 131, S. 104110. http://doi.org/10.1016/j.jbi.2022.104110.

Lewis, J. T.; Brazier, E.; Katz, B.; Nash, D. & Duda, S. N. (2022). A Method for Generating Dashboard Aggregations in an International HIV Consortium. Stud Health Technol Inform, 290, S. 1048–1049. http://doi.org/10.3233/SHTI220261.

Walker, T. M.; Miotto, P.; Koser, C. U.; Fowler, P. W.; Knaggs, J. et al. (2022). The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: A genotypic analysis. Lancet Microbe, 3 (4), S. e265–e273. http://doi.org/10.1016/S2666-5247(21)00301-3.

Coelho, L. E.; Jenkins, C. A.; Shepherd, B. E.; Pape, J. W.; Mejia Cordero, F. et al. (2022). Weight gain post-ART in HIV+ Latinos/as differs in the USA, Haiti, and Latin America. Lancet Reg Health Am, 8, S. 100173. http://doi.org/10.1016/j.lana.2021.100173.

Antimycobacterial Susceptibility Testing, Group (2022). Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment. Eur Respir J, 59 (4), S. 2200166. http://doi.org/10.1183/13993003.00166-2022.

Justice, A. C.; Goetz, M. B.; Stewart, C. N.; Hogan, B. C.; Humes, E. et al. (2022). Delayed presentation of HIV among older individuals: a growing problem. Lancet HIV, 9 (4), S. e269–e280. http://doi.org/10.1016/S2352-3018(22)00003-0.

Collaborative Initiative for Paediatric, H. I. V. Education; Research Global Cohort, Collaboration; Jesson, J.; Crichton, S.; Quartagno, M. et al. (2022). Growth and CD4 patterns of adolescents living with perinatally acquired HIV worldwide, a CIPHER cohort collaboration analysis. J Int AIDS Soc, 25 (3), S. e25871. http://doi.org/10.1002/jia2.25871.

Romo, M. L.; Patel, R. C.; Edwards, J. K.; Humphrey, J. M.; Musick, B. S. et al. (2022). Disparities in Dolutegravir Uptake Affecting Females of Reproductive Age With HIV in Low- and Middle-Income Countries After Initial Concerns About Teratogenicity : An Observational Study. Ann Intern Med, 175 (1), S. 84–94. http://doi.org/10.7326/M21-3037.

Zurcher, K.; Cox, S. R.; Ballif, M.; Enane, L. A.; Marcy, O. et al. (2022). Integrating services for HIV and multidrug-resistant tuberculosis: A global cross-sectional survey among ART clinics in low- and middle-income countries. PLOS Glob Public Health, 2 (3), S. e0000180. http://doi.org/10.1371/journal.pgph.0000180.

Seth, D.; Williams, V. L.; McMahon, D. E.; Regan, S.; Busakhala, N. et al. (2021). The role of dermatology in Kaposi sarcoma diagnosis across 3 regions in sub-Saharan Africa. J Am Acad Dermatol, 85 (6), S. 1414–1417. http://doi.org/10.1016/j.jaad.2020.07.114.

Han, W. M.; Law, M. G.; Egger, M.; Wools-Kaloustian, K.; Moore, R. et al. (2021). Global estimates of viral suppression in children and adolescents and adults on antiretroviral therapy adjusted for missing viral load measurements: a multiregional, retrospective cohort study in 31 countries. Lancet HIV, 8 (12), S. e766–e775. http://doi.org/10.1016/S2352-3018(21)00265-4.

Brazier, E.; Tymejczyk, O.; Zaniewski, E.; Egger, M.; Wools-Kaloustian, K. et al. (2021). Effects of National Adoption of Treat-All Guidelines on Pre-Antiretroviral Therapy (ART) CD4 Testing and Viral Load Monitoring After ART initiation: A Regression Discontinuity Analysis. Clin Infect Dis, 73 (6), S. e1273–e1281. http://doi.org/10.1093/cid/ciab222.

Kassanjee, R.; Johnson, L. F.; Zaniewski, E.; Ballif, M.; Christ, B. et al. (2021). Global HIV mortality trends among children on antiretroviral treatment corrected for under-reported deaths: an updated analysis of the International epidemiology Databases to Evaluate AIDS collaboration. J Int AIDS Soc, 24 Suppl 5 (Suppl 5), S. e25780. http://doi.org/10.1002/jia2.25780.

Zurcher, K.; Reichmuth, M. L.; Ballif, M.; Loiseau, C.; Borrell, S. et al. (2021). Mortality from drug-resistant tuberculosis in high-burden countries comparing routine drug susceptibility testing with whole-genome sequencing: a multicentre cohort study. Lancet Microbe, 2 (7), S. e320–e330. http://doi.org/10.1016/S2666-5247(21)00044-6.

Iyun, V.; Technau, K. G.; Vinikoor, M.; Yotebieng, M.; Vreeman, R. et al. (2021). Variations in the characteristics and outcomes of children living with HIV following universal ART in sub-Saharan Africa (2006-17): a retrospective cohort study. Lancet HIV, 8 (6), S. e353–e362. http://doi.org/10.1016/S2352-3018(21)00004-7.

Tsondai, P. R.; Davies, M. A.; Singtoroj, T.; Maxwell, N.; McGowan, C. C. et al. (2021). Improving Methods to Classify Perinatal versus Nonperinatal HIV Acquisition in Young Adolescents 10-14 Years of Age. Pediatr Infect Dis J, 40 (5), S. 453–456. http://doi.org/10.1097/INF.0000000000003059.

Desmonde, S.; Ciaranello, A. L.; Malateste, K.; Musick, B.; Patten, G. et al. (2021). Age-specific mortality rate ratios in adolescents and youth aged 10-24 years living with perinatally versus nonperinatally acquired HIV. AIDS, 35 (4), S. 625–632. http://doi.org/10.1097/QAD.0000000000002765.

Reichmuth, M. L.; Homke, R.; Zurcher, K.; Sander, P.; Avihingsanon, A. et al. (2020). Natural Polymorphisms in Mycobacterium tuberculosis Conferring Resistance to Delamanid in Drug-Naive Patients. Antimicrob Agents Chemother, 64 (11). http://doi.org/10.1128/AAC.00513-20.

Desmonde, S.; Neilan, A. M.; Musick, B.; Patten, G.; Chokephaibulkit, K. et al. (2020). Time-varying age- and CD4-stratified rates of mortality and WHO stage 3 and stage 4 events in children, adolescents and youth 0 to 24 years living with perinatally acquired HIV, before and after antiretroviral therapy initiation in the paediatric IeDEA Global Cohort Consortium. J Int AIDS Soc, 23 (10), S. e25617. http://doi.org/10.1002/jia2.25617.

Loiseau, C.; Brites, D.; Reinhard, M.; Zurcher, K.; Borrell, S. et al. (2020). HIV Coinfection Is Associated with Low-Fitness rpoB Variants in Rifampicin-Resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother, 64 (10). http://doi.org/10.1128/AAC.00782-20.

Tymejczyk, O.; Brazier, E.; Wools-Kaloustian, K.; Davies, M. A.; Dilorenzo, M. et al. (2020). Impact of Universal Antiretroviral Treatment Eligibility on Rapid Treatment Initiation Among Young Adolescents with Human Immunodeficiency Virus in Sub-Saharan Africa. J Infect Dis, 222 (5), S. 755–764. http://doi.org/10.1093/infdis/jiz547.

Parcesepe, A. M.; Lancaster, K.; Edelman, E. J.; DeBoni, R.; Ross, J. et al. (2020). Substance use service availability in HIV treatment programs: Data from the global IeDEA consortium, 2014-2015 and 2017. PLoS One, 15 (8), S. e0237772. http://doi.org/10.1371/journal.pone.0237772.

Patten, G.; Puthanakit, T.; McGowan, C. C.; Wools-Kaloustian, K.; Hazra, R. et al. (2020). Raltegravir use and outcomes among children and adolescents living with HIV in the IeDEA global consortium. J Int AIDS Soc, 23 (7), S. e25580. http://doi.org/10.1002/jia2.25580.

Jesson, J.; Desmonde, S.; Yiannoutsos, C. T.; Patten, G.; Malateste, K. et al. (2020). Weight-for-age distributions among children with HIV on antiretroviral therapy in the International epidemiology Databases to Evaluate AIDS (IeDEA) multiregional consortium. BMC Res Notes, 13 (1), S. 249. http://doi.org/10.1186/s13104-020-05081-7.

Chammartin, F.; Dao Ostinelli, C. H.; Anastos, K.; Jaquet, A.; Brazier, E. et al. (2020). International epidemiology databases to evaluate AIDS (IeDEA) in sub-Saharan Africa, 2012-2019. BMJ Open, 10 (5), S. e035246. http://doi.org/10.1136/bmjopen-2019-035246.

Humphrey, J. M.; Mpofu, P.; Pettit, A. C.; Musick, B.; Carter, E. J. et al. (2020). Mortality Among People With HIV Treated for Tuberculosis Based on Positive, Negative, or No Bacteriologic Test Results for Tuberculosis: The IeDEA Consortium. Open Forum Infect Dis, 7 (1), S. ofaa006. http://doi.org/10.1093/ofid/ofaa006.

Stover, J.; Glaubius, R.; Mofenson, L.; Dugdale, C. M.; Davies, M. A. et al. (2019). Updates to the Spectrum/AIM model for estimating key HIV indicators at national and subnational levels. AIDS, 33 Suppl 3 (Suppl 3), S. S227–S234. http://doi.org/10.1097/QAD.0000000000002357.

Pettit, A. C.; Jenkins, C. A.; Blevins Peratikos, M.; Yotebieng, M.; Diero, L. et al. (2019). Directly observed therapy and risk of unfavourable tuberculosis treatment outcomes among an international cohort of people living with HIV in low- and middle-income countries. J Int AIDS Soc, 22 (12), S. e25423. http://doi.org/10.1002/jia2.25423.

Boettiger, D. C.; Law, M. G.; Sohn, A. H.; Davies, M. A.; Wools-Kaloustian, K. et al. (2019). Temporal Trends in Co-trimoxazole Use Among Children on Antiretroviral Therapy and the Impact of Co-trimoxazole on Mortality Rates in Children Without Severe Immunodeficiency. J Pediatric Infect Dis Soc, 8 (5), S. 450–460. http://doi.org/10.1093/jpids/piy087.

Jesson, J.; Schomaker, M.; Malasteste, K.; Wati, D. K.; Kariminia, A. et al. (2019). Stunting and growth velocity of adolescents with perinatally acquired HIV: differential evolution for males and females. A multiregional analysis from the IeDEA global paediatric collaboration. J Int AIDS Soc, 22 (11), S. e25412. http://doi.org/10.1002/jia2.25412.

Zurcher, K.; Ballif, M.; Kiertiburanakul, S.; Chenal, H.; Yotebieng, M. et al. (2019). Diagnosis and clinical outcomes of extrapulmonary tuberculosis in antiretroviral therapy programmes in low- and middle-income countries: a multicohort study. J Int AIDS Soc, 22 (9), S. e25392. http://doi.org/10.1002/jia2.25392.

Brazier, E.; Maruri, F.; Duda, S. N.; Tymejczyk, O.; Wester, C. W. et al. (2019). Implementation of “Treat-all” at adult HIV care and treatment sites in the Global IeDEA Consortium: results from the Site Assessment Survey. J Int AIDS Soc, 22 (7), S. e25331. http://doi.org/10.1002/jia2.25331.

Tymejczyk, O.; Brazier, E.; Yiannoutsos, C. T.; Vinikoor, M.; van Lettow, M. et al. (2019). Changes in rapid HIV treatment initiation after national “treat all” policy adoption in 6 sub-Saharan African countries: Regression discontinuity analysis. PLoS Med, 16 (6), S. e1002822. http://doi.org/10.1371/journal.pmed.1002822.

Vreeman, R. C.; Scanlon, M. L.; Tu, W.; Slaven, J. E.; McAteer, C. I. et al. (2019). Validation of a self-report adherence measurement tool among a multinational cohort of children living with HIV in Kenya, South Africa and Thailand. J Int AIDS Soc, 22 (5), S. e25304. http://doi.org/10.1002/jia2.25304.

Gygli, S. M.; Keller, P. M.; Ballif, M.; Blochliger, N.; Homke, R. et al. (2019). Whole-Genome Sequencing for Drug Resistance Profile Prediction in Mycobacterium tuberculosis. Antimicrob Agents Chemother, 63 (4). http://doi.org/10.1128/AAC.02175-18.

Zurcher, K.; Ballif, M.; Fenner, L.; Borrell, S.; Keller, P. M. et al. (2019). Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort study. Lancet Infect Dis, 19 (3), S. 298–307. http://doi.org/10.1016/S1473-3099(18)30673-X.

Collaborative Initiative for Paediatric, H. I. V. Education & Research Global Cohort, Collaboration (2019). Incidence of switching to second-line antiretroviral therapy and associated factors in children with HIV: an international cohort collaboration. Lancet HIV, 6 (2), S. e105–e115. http://doi.org/10.1016/S2352-3018(18)30319-9.

Yotebieng, M.; Brazier, E.; Addison, D.; Kimmel, A. D.; Cornell, M. et al. (2019). Research priorities to inform “Treat All” policy implementation for people living with HIV in sub-Saharan Africa: a consensus statement from the International epidemiology Databases to Evaluate AIDS (IeDEA). J Int AIDS Soc, 22 (1), S. e25218. http://doi.org/10.1002/jia2.25218.

Nouaman, M. N.; Vinikoor, M.; Seydi, M.; Ekouevi, D. K.; Coffie, P. A. et al. (2018). High prevalence of binge drinking among people living with HIV in four African countries. J Int AIDS Soc, 21 (12), S. e25202. http://doi.org/10.1002/jia2.25202.

Kariminia, A.; Law, M.; Davies, M. A.; Vinikoor, M.; Wools-Kaloustian, K. et al. (2018). Mortality and losses to follow-up among adolescents living with HIV in the IeDEA global cohort collaboration. J Int AIDS Soc, 21 (12), S. e25215. http://doi.org/10.1002/jia2.25215.

Aids-defining Cancer Project Working Group of IeDea, Cohere in EuroCoord (2018). Non-Hodgkin lymphoma risk in adults living with HIV across five continents. AIDS, 32 (18), S. 2777–2786. http://doi.org/10.1097/QAD.0000000000002003.

Zaniewski, E.; Tymejczyk, O.; Kariminia, A.; Desmonde, S.; Leroy, V. et al. (2018). IeDEA-WHO Research-Policy Collaboration: contributing real-world evidence to HIV progress reporting and guideline development. J Virus Erad, 4 (Suppl 2), S. 9–15.

Panayidou, K.; Davies, M. A.; Anderegg, N.; Egger, M.; IeDea, Cohere Phacs et al. (2018). Global temporal changes in the proportion of children with advanced disease at the start of combination antiretroviral therapy in an era of changing criteria for treatment initiation. J Int AIDS Soc, 21 (11), S. e25200. http://doi.org/10.1002/jia2.25200.

Arrive, E.; Ayaya, S.; Davies, M. A.; Chimbetete, C.; Edmonds, A. et al. (2018). Models of support for disclosure of HIV status to HIV-infected children and adolescents in resource-limited settings. J Int AIDS Soc, 21 (7), S. e25157. http://doi.org/10.1002/jia2.25157.

Wools-Kaloustian, K.; Marete, I.; Ayaya, S.; Sohn, A. H.; Van Nguyen, L. et al. (2018). Time to First-Line ART Failure and Time to Second-Line ART Switch in the IeDEA Pediatric Cohort. J Acquir Immune Defic Syndr, 78 (2), S. 221–230. http://doi.org/10.1097/QAI.0000000000001667.

Desmonde, Sophie; Tanser, Franck; Vreeman, Rachel; Takassi, Elom; Edmonds, Andrew et al. (2018). Access to antiretroviral therapy in HIV-infected children aged 0-19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004-2015: A prospective cohort study. PLoS Medicine, 15 (5), S. e1002565–e1002565. http://doi.org/10.1371/journal.pmed.1002565.

Tymejczyk, O.; Brazier, E.; Yiannoutsos, C.; Wools-Kaloustian, K.; Althoff, K. et al. (2018). HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: A metaregression analysis of programmatic data from 22 countries. PLoS Med, 15 (3), S. e1002534. http://doi.org/10.1371/journal.pmed.1002534.

Parcesepe, A. M.; Mugglin, C.; Nalugoda, F.; Bernard, C.; Yunihastuti, E. et al. (2018). Screening and management of mental health and substance use disorders in HIV treatment settings in low- and middle-income countries within the global IeDEA consortium. J Int AIDS Soc, 21 (3), S. e25101. http://doi.org/10.1002/jia2.25101.

Collaborative Initiative for Paediatric, H. I. V. Education; Research Global Cohort, Collaboration; Slogrove, A. L.; Schomaker, M.; Davies, M. A. et al. (2018). The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis. PLoS Med, 15 (3), S. e1002514. http://doi.org/10.1371/journal.pmed.1002514.

Haas, A. D.; Zaniewski, E.; Anderegg, N.; Ford, N.; Fox, M. P. et al. (2018). Retention and mortality on antiretroviral therapy in sub-Saharan Africa: collaborative analyses of HIV treatment programmes. J Int AIDS Soc, 21 (2), S. e25084–e25084. http://doi.org/10.1002/jia2.25084.

Cipher Global Cohort Collaboration (2018). Inequality in outcomes for adolescents living with perinatally acquired HIV in sub-Saharan Africa: a Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Cohort Collaboration analysis. J Int AIDS Soc, 21 Suppl 1 (Suppl Suppl 1), S. e25044–e25044. http://doi.org/10.1002/jia2.25044.

Coffie, P. A.; Egger, M.; Vinikoor, M. J.; Zannou, M.; Diero, L. et al. (2017). Trends in hepatitis B virus testing practices and management in HIV clinics across sub-Saharan Africa. BMC Infect Dis, 17 (Suppl 1), S. 706. http://doi.org/10.1186/s12879-017-2768-z.

Jiamsakul, A.; Kariminia, A.; Althoff, K. N.; Cesar, C.; Cortes, C. P. et al. (2017). HIV Viral Load Suppression in Adults and Children Receiving Antiretroviral Therapy-Results From the IeDEA Collaboration. J Acquir Immune Defic Syndr, 76 (3), S. 319–329. http://doi.org/10.1097/QAI.0000000000001499.

AIDS-defining Cancer Project Working Group for IeDEA and COHERE in EuroCoord & AIDS-defining Cancer Project Working Group for IeDEA and COHERE in EuroCoord (2017). Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 65 (8), S. 1316–1326. http://doi.org/10.1093/cid/cix480.

Semeere, A.; Freeman, E.; Wenger, M.; Glidden, D.; Bwana, M. et al. (2017). Updating vital status by tracking in the community among patients with epidemic Kaposi sarcoma who are lost to follow-up in sub-Saharan Africa. BMC Cancer, 17 (1), S. 611. http://doi.org/10.1186/s12885-017-3549-1.

Brown, Steven A.; Abbas, Salma; Davies, Mary-Ann; Bunupuradah, Torsak; Sohn, Annette H. et al. (2017). Brief Report: Pediatric Cancer Burden and Treatment Resources Within the Pediatric IeDEA Consortium. JAIDS Journal of Acquired Immune Deficiency Syndromes, 76 (1), S. 60–64. http://doi.org/10.1097/QAI.0000000000001453.

Carlucci, J. G.; Blevins Peratikos, M.; Kipp, A. M.; Lindegren, M. L.; Du, Q. T. et al. (2017). Tuberculosis Treatment Outcomes Among HIV/TB-Coinfected Children in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Network. J Acquir Immune Defic Syndr, 75 (2), S. 156–163. http://doi.org/10.1097/QAI.0000000000001335.

Schomaker, M.; Leroy, V.; Wolfs, T.; Technau, K. G.; Renner, L. et al. (2017). Optimal timing of antiretroviral treatment initiation in HIV-positive children and adolescents: a multiregional analysis from Southern Africa, West Africa and Europe. Int J Epidemiol, 46 (2), S. 453–465. http://doi.org/10.1093/ije/dyw097.

Anderegg, Nanina; Johnson, Leigh F.; Zaniewski, Elizabeth; Althoff, Keri N.; Balestre, Eric et al. (2017). All-cause mortality in HIV-positive adults starting combination antiretroviral therapy: correcting for loss to follow-up. AIDS (London, England), 31 Suppl 1 (Suppl 1), S. S31–S40. http://doi.org/10.1097/QAD.0000000000001321.

Clouse, K.; Blevins, M.; Lindegren, M. L.; Yotebieng, M.; Nguyen, D. T. et al. (2017). Low implementation of Xpert MTB/RIF among HIV/TB co-infected adults in the International epidemiologic Databases to Evaluate AIDS (IeDEA) program. PLoS One, 12 (2), S. e0171384. http://doi.org/10.1371/journal.pone.0171384.

Brennan, Alana T.; Davies, Mary-Ann; Bor, Jacob; Wandeler, Gilles; Stinson, Kathryn et al. (2017). Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa? AIDS (London, England), 31 (1), S. 147–157. http://doi.org/10.1097/QAD.0000000000001307.

Pediatric Aids-Defining Cancer Project Working Group for IeDea Southern Africa, TApHOD; Cohere in EuroCoord; Rohner, E.; Schmidlin, K.; Zwahlen, M. et al. (2016). Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia. Clin Infect Dis, 63 (9), S. 1245–1253. http://doi.org/10.1093/cid/ciw519.

Rachlis, B.; Karwa, R.; Chema, C.; Pastakia, S.; Olsson, S. et al. (2016). Targeted Spontaneous Reporting: Assessing Opportunities to Conduct Routine Pharmacovigilance for Antiretroviral Treatment on an International Scale. Drug Saf, 39 (10), S. 959–976. http://doi.org/10.1007/s40264-016-0434-9.

Charles, M. K.; Lindegren, M. L.; Wester, C. W.; Blevins, M.; Sterling, T. R. et al. (2016). Implementation of Tuberculosis Intensive Case Finding, Isoniazid Preventive Therapy, and Infection Control (“Three I’s”) and HIV-Tuberculosis Service Integration in Lower Income Countries. PLoS One, 11 (4), S. e0153243. http://doi.org/10.1371/journal.pone.0153243.

Schomaker, M.; Davies, M. A.; Malateste, K.; Renner, L.; Sawry, S. et al. (2016). Growth and Mortality Outcomes for Different Antiretroviral Therapy Initiation Criteria in Children Ages 1-5 Years: A Causal Modeling Analysis. Epidemiology, 27 (2), S. 237–246. http://doi.org/10.1097/EDE.0000000000000412.

Freeman, E.; Semeere, A.; Wenger, M.; Bwana, M.; Asirwa, F. C. et al. (2016). Pitfalls of practicing cancer epidemiology in resource-limited settings: the case of survival and loss to follow-up after a diagnosis of Kaposi’s sarcoma in five countries across sub-Saharan Africa. BMC Cancer, 16 (1), S. 65. http://doi.org/10.1186/s12885-016-2080-0.

Coleman, J. S.; Cespedes, M. S.; Cu-Uvin, S.; Kosgei, R. J.; Maloba, M. et al. (2016). An Insight Into Cervical Cancer Screening and Treatment Capacity in Sub Saharan Africa. J Low Genit Tract Dis, 20 (1), S. 31–37. http://doi.org/10.1097/LGT.0000000000000165.

Huisin ’t Veld, D.; Balestre, E.; Buyze, J.; Menten, J.; Jaquet, A. et al. (2015). Determinants of Weight Evolution Among HIV-Positive Patients Initiating Antiretroviral Treatment in Low-Resource Settings. J Acquir Immune Defic Syndr, 70 (2), S. 146–154. http://doi.org/10.1097/QAI.0000000000000691.

Haas, A. D.; Keiser, O.; Balestre, E.; Brown, S.; Bissagnene, E. et al. (2015). Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis. Lancet HIV, 2 (7), S. e271-8. http://doi.org/10.1016/S2352-3018(15)00087-9.

Ballif, M.; Renner, L.; Claude Dusingize, J.; Leroy, V.; Ayaya, S. et al. (2015). Tuberculosis in Pediatric Antiretroviral Therapy Programs in Low- and Middle-Income Countries: Diagnosis and Screening Practices. J Pediatric Infect Dis Soc, 4 (1), S. 30–38. http://doi.org/10.1093/jpids/piu020.

Duda, S. N.; Farr, A. M.; Lindegren, M. L.; Blevins, M.; Wester, C. W. et al. (2014). Characteristics and comprehensiveness of adult HIV care and treatment programmes in Asia-Pacific, sub-Saharan Africa and the Americas: results of a site assessment conducted by the International epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration. J Int AIDS Soc, 17 (1), S. 19045. http://doi.org/10.7448/IAS.17.1.19045 19045.

Ballif, M.; Nhandu, V.; Wood, R.; Dusingize, J. C.; Carter, E. J. et al. (2014). Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries. Int J Tuberc Lung Dis, 18 (11), S. 1327–1336. http://doi.org/10.5588/ijtld.14.0106.

Boulle, A.; Schomaker, M.; May, M. T.; Hogg, R. S.; Shepherd, B. E. et al. (2014). Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies. PLoS Med, 11 (9), S. e1001718. http://doi.org/10.1371/journal.pmed.1001718.

Ciaranello, A. L.; Morris, B. L.; Walensky, R. P.; Weinstein, M. C.; Ayaya, S. et al. (2013). Validation and calibration of a computer simulation model of pediatric HIV infection. PLoS One, 8 (12), S. e83389. http://doi.org/10.1371/journal.pone.0083389.

Fenner, L.; Ballif, M.; Graber, C.; Nhandu, V.; Dusingize, J. C. et al. (2013). Tuberculosis in antiretroviral treatment programs in lower income countries: availability and use of diagnostics and screening. PLoS One, 8 (10), S. e77697. http://doi.org/10.1371/journal.pone.0077697.

Calmy, A.; Balestre, E.; Bonnet, F.; Boulle, A.; Sprinz, E. et al. (2012). Mean CD4 cell count changes in patients failing a first-line antiretroviral therapy in resource-limited settings. BMC Infect Dis, 12 (1), S. 147. http://doi.org/10.1186/1471-2334-12-147.

Fenner, L.; Gagneux, S.; Janssens, J. P.; Fehr, J.; Cavassini, M. et al. (2012). Tuberculosis in HIV-negative and HIV-infected patients in a low-incidence country: clinical characteristics and treatment outcomes. PLoS One, 7 (3), S. e34186. http://doi.org/10.1371/journal.pone.0034186.

Chi, B. H.; Yiannoutsos, C. T.; Westfall, A. O.; Newman, J. E.; Zhou, J. et al. (2011). Universal definition of loss to follow-up in HIV treatment programs: a statistical analysis of 111 facilities in Africa, Asia, and Latin America. PLoS Med, 8 (10), S. e1001111. http://doi.org/10.1371/journal.pmed.1001111.

TREAT Asia Pediatric HIV Observational Database (TApHOD) & International Epidemiologic Databases to Evaluate AIDS (IeDEA) Southern Africa Paediatric Group (2011). A biregional survey and review of first-line treatment failure and second-line paediatric antiretroviral access and use in Asia and southern Africa. Journal of the International AIDS Society, 14, S. 7. http://doi.org/10.1186/1758-2652-14-7.

May, M.; Boulle, A.; Phiri, S.; Messou, E.; Myer, L. et al. (2010). Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes. Lancet, 376 (9739), S. 449–457. http://doi.org/10.1016/S0140-6736(10)60666-6.